Cargando…

Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum

Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiambeng, Timothy N., Roberts, David S., Brown, Kyle A., Zhu, Yanlong, Chen, Bifan, Wu, Zhijie, Mitchell, Stanford D., Guardado-Alvarez, Tania M., Jin, Song, Ge, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411019/
https://www.ncbi.nlm.nih.gov/pubmed/32764543
http://dx.doi.org/10.1038/s41467-020-17643-1
_version_ 1783568288926662656
author Tiambeng, Timothy N.
Roberts, David S.
Brown, Kyle A.
Zhu, Yanlong
Chen, Bifan
Wu, Zhijie
Mitchell, Stanford D.
Guardado-Alvarez, Tania M.
Jin, Song
Ge, Ying
author_facet Tiambeng, Timothy N.
Roberts, David S.
Brown, Kyle A.
Zhu, Yanlong
Chen, Bifan
Wu, Zhijie
Mitchell, Stanford D.
Guardado-Alvarez, Tania M.
Jin, Song
Ge, Ying
author_sort Tiambeng, Timothy N.
collection PubMed
description Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the blood proteome. Here, we develop an integrated nanoproteomics method coupling peptide-functionalized superparamagnetic nanoparticles (NPs) with top-down MS for the enrichment and comprehensive analysis of cardiac troponin I (cTnI), a gold-standard cardiac biomarker, directly from serum. These NPs enable the sensitive enrichment of cTnI (<1 ng/mL) with high specificity and reproducibility, while simultaneously depleting highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI). We demonstrate that top-down nanoproteomics can provide high-resolution proteoform-resolved molecular fingerprints of diverse cTnI proteoforms to establish proteoform-pathophysiology relationships. This scalable and reproducible antibody-free strategy can generally enable the proteoform-resolved analysis of low-abundance proteins directly from serum to reveal previously unachievable molecular details.
format Online
Article
Text
id pubmed-7411019
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74110192020-08-17 Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum Tiambeng, Timothy N. Roberts, David S. Brown, Kyle A. Zhu, Yanlong Chen, Bifan Wu, Zhijie Mitchell, Stanford D. Guardado-Alvarez, Tania M. Jin, Song Ge, Ying Nat Commun Article Top-down mass spectrometry (MS)-based proteomics provides a comprehensive analysis of proteoforms to achieve a proteome-wide understanding of protein functions. However, the MS detection of low-abundance proteins from blood remains an unsolved challenge due to the extraordinary dynamic range of the blood proteome. Here, we develop an integrated nanoproteomics method coupling peptide-functionalized superparamagnetic nanoparticles (NPs) with top-down MS for the enrichment and comprehensive analysis of cardiac troponin I (cTnI), a gold-standard cardiac biomarker, directly from serum. These NPs enable the sensitive enrichment of cTnI (<1 ng/mL) with high specificity and reproducibility, while simultaneously depleting highly abundant proteins such as human serum albumin (>10(10) more abundant than cTnI). We demonstrate that top-down nanoproteomics can provide high-resolution proteoform-resolved molecular fingerprints of diverse cTnI proteoforms to establish proteoform-pathophysiology relationships. This scalable and reproducible antibody-free strategy can generally enable the proteoform-resolved analysis of low-abundance proteins directly from serum to reveal previously unachievable molecular details. Nature Publishing Group UK 2020-08-06 /pmc/articles/PMC7411019/ /pubmed/32764543 http://dx.doi.org/10.1038/s41467-020-17643-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Tiambeng, Timothy N.
Roberts, David S.
Brown, Kyle A.
Zhu, Yanlong
Chen, Bifan
Wu, Zhijie
Mitchell, Stanford D.
Guardado-Alvarez, Tania M.
Jin, Song
Ge, Ying
Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title_full Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title_fullStr Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title_full_unstemmed Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title_short Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
title_sort nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411019/
https://www.ncbi.nlm.nih.gov/pubmed/32764543
http://dx.doi.org/10.1038/s41467-020-17643-1
work_keys_str_mv AT tiambengtimothyn nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT robertsdavids nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT brownkylea nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT zhuyanlong nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT chenbifan nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT wuzhijie nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT mitchellstanfordd nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT guardadoalvareztaniam nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT jinsong nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum
AT geying nanoproteomicsenablesproteoformresolvedanalysisoflowabundanceproteinsinhumanserum